Top Markets
Coin of the day
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation

InVivo Therapeutics Holdings Corporation

NVIV
Rank in Stocks #39771
InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm,... InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold. This device is engineered to be implanted directly at the site of injury within the spinal cord, aiming to treat acute SCI. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
Share Price
$0.26
Last synced: 2024-03-11
Market Cap
$356.29K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade InVivo Therapeutics Holdings Corporation (NVIV)

Category

Price of NVIV with the market cap of B
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation
NVIV
$0.26
Market Capitalization of InVivo Therapeutics Holdings Corporation(NVIV)
Market Cap: $356.29K
As of August 2026 InVivo Therapeutics Holdings Corporation has a market cap of $356.29K. This makes InVivo Therapeutics Holdings Corporation the world's 39771st most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of InVivo Therapeutics Holdings Corporation from 2010 to 2026
NVIV compared with Top 5 Most Popular stocks
Price of NVIV Asset B Mkt. of B Results
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation
$3,991,379 $356.29K
$5.470T +1,535,145,518.20%
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation
$3,259,832 $356.29K
$4.467T +1,253,781,309.37%
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation
$3,046,246 $356.29K
$4.174T +1,171,632,897.01%
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation
$2,700,120 $356.29K
$3.700T +1,038,507,667.79%
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation
$2,082,948 $356.29K
$2.854T +801,133,718.95%